Clinical Trial Update: Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial assessing whether adding venetoclax to the fludarabine/melphalan conditioning regimen improves outcomes for adults over 50 undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Fludarabine (Fludarabine)
• Melphalan (Melphalan)
• Venetoclax (venetoclax)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Venentoclax, Myeloid Malignancies | Phase 3 | Status: RECRUITING